Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohn's disease

Pediatric Nephrology

Volumn 27, Issue 7, 2012, Pages 1103-1109

  Hueppelshaeuser, Renate ^a   Von Unruh, Gerd E ^b   Habbig, Sandra ^a   Beck, Bodo B ^a   Buderus, Stephan ^c   Hesse, Albrecht ^b   Hoppe, Bernd ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c Department of Pediatrics   (Germany)

Author keywords

Crohn's disease; Renal failure; Secondary hyperoxaluria; Systemic oxalosis; Urolithiasis

Indexed keywords

CALCIUM OXALATE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIET; FEMALE; HUMAN; HYPEROXALURIA; INTESTINE ABSORPTION; MALE; OXALOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; URINALYSIS; URINARY EXCRETION; UROLITHIASIS;

ADOLESCENT; ADULT; CALCIUM OXALATE; CHILD; CROHN DISEASE; FEMALE; HUMANS; HYPEROXALURIA; MALE; MIDDLE AGED; UROLITHIASIS; YOUNG ADULT;

EID: 84863985469     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-012-2126-8     Document Type: Article

References (36)

1. VanDervoort K, Wiesen J, Frank R, Vento S, Crosby V, Chandra M, Trachtman H (2007) Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol 177:2300-2305 (Pubitemid 46726436)
2. Sas DJ, Hulsey TC, Shatat IF, Orak JK (2010) Increasing incidence of kidney stones in children evaluated in the emergency department. J Pediatr 157:132-137
3. Andersson H, Bosaeus I, Fasth S, Hellberg R, Hulten L (1987) Cholelithiasis and urolithiasis in Crohn's disease. Scand J Gastro-enterol 22:253-256 (Pubitemid 17024414)
4. Hoppe B, Leumann E, von Unruh G, Laube N, Hesse A (2003) Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Front Biosci 8:e437-e443
5. Neuhaus TJ, Belzer T, Blau N, Hoppe B, Sidhu H, Leumann E (2000) Urinary oxalate excretion in urolithiasis and nephrocalci-nosis. Arch Dis Child 82:322-326 (Pubitemid 30305652)
6. Holmes RP, Goodman HO, Assimos DG (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270-276 (Pubitemid 32055235)
7. Williams HE, Wandzilak TR (1989) Oxalate synthesis, transport and the hyperoxaluric syndromes. J Urol 141:742-749
8. Leumann E, Hoppe B (2001) The primary hyperoxalurias. J Am Soc Nephrol 12:1986-1993 (Pubitemid 32801376)
9. Binder HJ (1974) Intestinal oxalate absorption. Gastroenterology 67:441-446
10. Dobbins JW, Binder HJ (1976) Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology 70:1096-1100
11. Chadwick VS, Modha K, Dowling RH (1973) Mechanism for hyperoxaluria in patients with ileal dysfunction. N Engl J Med 289:172-176
12. Booth CC, Babouris N, Hanna S, Macintyre I (1963) Incidence of hypomagnesaemia in intestinal malabsorption. Br Med J 2:141-144
13. Trinchieri A, Lizzano R, Castelnuovo C, Zanetti G, Pisani E (2002) Urinary patterns of patients with renal stones associated with chronic inflammatory bowel disease. Arch Ital Urol Androl 74:61-64
14. Rudman D, Dedonis JL, Fountain MT, Chandler JB, Gerron GG, Fleming GA, Kutner MH (1980) Hypocitraturia in patients with gastrointestinal malabsorption. N Engl J Med 303:657-661 (Pubitemid 10053699)
15. Dobbins JW (1985) Nephrolithiasis and intestinal disease. J Clin Gastroenterol 7:21-24 (Pubitemid 15126538)
16. Caudarella R, Rizzoli E, Pironi L, Malavolta N, Martelli G, Poggioli G, Gozzetti G, Miglioli M (1993) Renal stone formation in patients with inflammatory bowel disease. Scanning Microsc 7:371-379, discussion 379-380
17. Hylander E, Jarnum S, Frandsen I (1979) Urolithiasis and hyper-oxaluria in chronic inflammatory bowel disease. Scand J Gastro-enterol 14:475-479 (Pubitemid 9232242)
18. Kyle J (1980) Urinary complications of Crohn's disease. World J Surg 4:153-160 (Pubitemid 10022109)
19. Beck B, Habbig S, Feldkötter M, Wolf M, Bangen U, Michalk D, Stapenhorst L, Burst V, Stippel D, Fries J, Hoppe B (2008) How to handle the dilemma of ESRF and systemic oxalosis in short bowel syndrome from Crohn's disease-a potential application for Oxa-lobacter formigenes. Pediatr Nephrol 23:P065
20. Dick PT, Shuckett BM, Tang B, Daneman A, Kooh SW (1999) Observer reliability in grading nephrocalcinosis on ultrasound examinations in children. Pediatr Radiol 29:68-72 (Pubitemid 29132590)
21. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259-263
22. Sikora P, von Unruh GE, Beck B, Feldkotter M, Zajaczkowska M, Hesse A, Hoppe B (2008) [13C2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria. Kidney Int 73:1181-1186 (Pubitemid 351620437)
23. von Unruh GE, Langer MA, Paar DW, Hesse A (1998) Mass spectrometric-selected ion monitoring assay for an oxalate absorption test applying [13C2]oxalate. J Chromatogr B: Biomed Sci Appl 716:343-349 (Pubitemid 28464580)
24. Hoppe B, Jahnen A, Bach D, Hesse A (1997) Urinary calcium oxalate saturation in healthy infants and children. J Urol 158:557-559 (Pubitemid 27327715)
25. Hylander E, Jarnum S, Jensen HJ, Thale M (1978) Enteric hyper-oxaluria: dependence on small intestinal resection, colectomy, and steatorrhoea in chronic inflammatory bowel disease. Scand J Gas-troenterol 13:577-588 (Pubitemid 9003936)
26. Hesse A, Schneeberger W, Engfeld S, Von Unruh GE, Sauerbruch T (1999) Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate. J Am Soc Nephrol 10 [Suppl 14]:S329-S333 (Pubitemid 29498574)
27. Asplin JR (2002) Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin North Am 31:927-949 (Pubitemid 35403491)
28. Sikora P, Zajaczkowska M, Hoppe B (2009) Assessment of crystallization risk formulas in pediatric calcium stone-formers. Pediatr Nephrol 24:1997-2003
29. Laube N, Hoppe B, Hesse A (2005) Problems in the investigation of urine from patients suffering from primary hyperoxaluria type 1. Urol Res 33:394-397 (Pubitemid 41752064)
30. von Unruh GE, Voss S, Sauerbruch T, Hesse A (2003) Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2]oxalate absorption test. J Urol 169:687-690 (Pubitemid 36133023)
31. El-Habet AE, el-Sewedy SM, el-Sharaky A, Gaafar NK, Abdel-Rafee A, Hamoud F (1987) Biochemical studies on bilharzial and non-bilharzial hyperoxaluria: effect of pyridoxine and allopurinol treatment. Biochem Med Metab Biol 38:1-8 (Pubitemid 17129628)
32. Zimmermann DJ, Hesse A, von Unruh GE (2005) Influenceofahigh-oxalate diet on intestinal oxalate absorption. World J Urol 23:324-329 (Pubitemid 43118488)
33. Sidhu H, Schmidt ME, Cornelius JG, Thamilselvan S, Khan SR, Hesse A, Peck AB (1999) Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10 [Suppl 14]:S334-S340 (Pubitemid 29498575)
34. Kumar R, Mukherjee M, Bhandari M, Kumar A, Sidhu H, Mittal RD (2002) Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India. Eur Urol 41:318-322 (Pubitemid 35303432)
35. Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart CS (2002) Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol 68:3841-3847 (Pubitemid 34836692)
36. Hoppe B, Beck B, Gatter N, von Unruh G, Tischer A, Hesse A, Laube N, Kaul P, Sidhu H (2006) Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int 70:1305-1311 (Pubitemid 44435182)